MSB 4.89% $1.07 mesoblast limited

Thanks for posting & yes good read. I watched the FDA’s 2024...

  1. 6,783 Posts.
    lightbulb Created with Sketch. 1469

    Thanks for posting & yes good read. I watched the FDA’s 2024 rare disease presentation on utube. I’d like to add patient voice is also very important. Patients tend to a little more direct & less fluff. Must be due to the death sentence many are facing.

    If only our young sr-aGVHD patients could talk & tell of their excruciating, painful, & fearful fight for life. Those parents who spoke at our 2020 ODAC meeting told of the horrible effects of this terrible disease & the affects on their children’s bodies, along with the lifelong affects of having Ruxolitnib which had failed

    Mesoblast has been listening all along.
    MSB SHs listened to that meeting & the voices of parents & patients will never be forgotten, regardless of any SP.
    FDA… I hope they are listening because the data supports this treatment being made available to those who have to fight to live, only to find themselves in a losing battle.

    Full credit to Peter Marks for catching up & pulling others along to the reality of modern & innovative medical treatments!

 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.07
Change
-0.055(4.89%)
Mkt cap ! $1.221B
Open High Low Value Volume
$1.14 $1.16 $1.06 $8.816M 8.055M

Buyers (Bids)

No. Vol. Price($)
1 280000 $1.07
 

Sellers (Offers)

Price($) Vol. No.
$1.07 2000 1
View Market Depth
Last trade - 16.10pm 29/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.